세계의 산소 요법 장비 시장 : 인사이트, 경쟁 구도, 시장 예측(-2032년)

Oxygen Therapy Equipment Market Summary

• The global oxygen therapy equipment market is expected to increase from USD 3,295.77 million in 2024 to USD 5,866.74 million by 2032, reflecting strong and sustained growth.
• The global oxygen therapy equipment market is growing at a CAGR of 7.52% during the forecast period from 2025 to 2032.
• The global oxygen therapy equipment market is witnessing robust growth driven by the rising prevalence of respiratory diseases, expanding use in critical care, and rapid technological advancements. Increasing cases of COPD, asthma, and other chronic lung conditions have heightened the demand for continuous oxygen support in both hospitals and home care settings. In critical care units, oxygen devices are indispensable for managing patients with severe respiratory or cardiac complications. Simultaneously, innovations such as AI-integrated concentrators, real-time monitoring, and portable designs are improving treatment precision and patient convenience. Together, these factors are fueling widespread adoption and strengthening the market's growth trajectory.
• The leading companies operating in the oxygen therapy equipment market include Koninklijke Philips N.V., Invacare Corporation, Inogen, Inc., Dragerwerk AG & Co. KgaA, ICU Medical, Inc., CAIRE Inc., Fisher & Paykel Healthcare Limited, Armstrong Medical, Vyaire Medical, Inc., Hamilton Medical, Shenzhen Comen Medical Instruments Co., Ltd., BMC Medical Co., Ltd., Allied Medical Limited, Teleflex Incorporated, HERSILL, Chart Industries, Inc., DeVilbiss Healthcare LLC, GCE Group, Oxygen Solutions Inc., Besco Medical Limited, and others.
• North America holds the highest share in the global oxygen therapy equipment market, driven by a well-established healthcare infrastructure, a high prevalence of chronic respiratory and other chronic diseases, and a growing aging population. The region's advanced adoption of medical technologies, including portable and stationary oxygen concentrators, AI-integrated monitoring systems, and smart oxygen delivery devices, further reinforces its market dominance. Rising demand for home-based oxygen therapy, coupled with continuous technological innovation and supportive patient programs, is accelerating adoption and ensuring sustained growth. These factors collectively position North America as a leading and highly influential market in the global oxygen therapy equipment landscape.
• Within the product type segment of the oxygen therapy equipment market, the system catheters category is projected to hold the largest share in 2024.

Factors Contributing to the Growth of the Oxygen Therapy Equipment Market

• Increase in the Cases of Respiratory Disorders Leading to Surge in the Oxygen Therapy Equipment Market: The increasing prevalence of chronic and acute respiratory diseases, such as chronic obstructive pulmonary disease (COPD), asthma, sleep apnea, and pneumonia, is one of the primary drivers of the oxygen therapy equipment market. According to the World Health Organization (WHO), COPD remains a leading cause of morbidity and mortality worldwide, particularly in aging populations and regions with high air pollution levels. The growing number of patients suffering from respiratory insufficiency and hypoxemia has significantly elevated the demand for oxygen concentrators, cylinders, and portable oxygen devices. Moreover, lifestyle factors such as smoking, occupational exposure to harmful gases, and urban pollution are contributing to rising respiratory complications, leading to higher oxygen therapy adoption in both clinical and home care settings. This surge in disease burden continues to propel the market forward as healthcare systems prioritize long-term respiratory support solutions.
• Significant Usage of These Devices in Critical Care: Oxygen therapy equipment plays a vital role in critical care environments, where maintaining optimal oxygen levels is essential for survival and recovery. Hospitals and intensive care units (ICUs) increasingly rely on advanced oxygen delivery systems for managing patients with severe respiratory distress, postoperative complications, and cardiac conditions. The growing incidence of emergency admissions due to respiratory failure, trauma, or sepsis further drives demand for high-performance stationary concentrators, ventilators, and oxygen delivery interfaces. Additionally, advancements in monitoring technologies and integrated oxygen flow systems enable clinicians to deliver precise oxygen concentrations, improving patient outcomes. With the expansion of critical care infrastructure and a growing emphasis on advanced respiratory support, the use of oxygen therapy equipment in acute settings continues to strengthen the market globally.
• Rapid Technical Innovation in Product Development: Continuous technological innovation is transforming the oxygen therapy equipment landscape by improving portability, efficiency, and patient comfort. Modern oxygen concentrators now feature compact designs, longer battery life, automated flow adjustment, and smart connectivity that allows remote monitoring and control. The integration of artificial intelligence (AI) and Internet of Things (IoT) technologies enables real-time tracking of oxygen usage and patient vitals, optimizing treatment adherence and clinical decision-making. Furthermore, manufacturers are introducing noise-reduction systems, lightweight materials, and user-friendly interfaces to enhance patient experience, particularly in home care settings. These innovations are expanding accessibility to oxygen therapy beyond hospitals, empowering patients to manage chronic respiratory conditions independently. As a result, rapid product advancements are driving wider adoption and sustaining the long-term growth trajectory of the oxygen therapy equipment market.

Oxygen Therapy Equipment Market Report Segmentation

This oxygen therapy equipment market report offers a comprehensive overview of the global oxygen therapy equipment market, highlighting key trends, growth drivers, challenges, and opportunities. It covers detailed market segmentation By Product Type (Systems [HFNO (High-Flow Nasal Cannula Oxygenation) Devices, Oxygen Concentrators, Ventilators, and Others] and Disposables and Accessories [Oxygen Masks, Nasal Cannulas, Resuscitator Bags, and Others]), Portability (Stationary and Portable), Application (COPD, Asthma, Respiratory Distress Syndrome, and Others), End-Users (Hospitals and Clinics, Ambulatory Surgical Centers, Home Care Settings, and Others), and geography. The report provides valuable insights into the competitive landscape, regulatory environment, and market dynamics across major markets, including North America, Europe, and Asia-Pacific. Featuring in-depth profiles of leading industry players and recent product innovations, this report equips businesses with essential data to identify market potential, develop strategic plans, and capitalize on emerging opportunities in the rapidly growing Oxygen Therapy Equipment market.

The oxygen therapy equipment refers to medical devices designed to deliver supplemental oxygen to individuals with respiratory disorders or conditions that cause low blood oxygen levels. These devices include oxygen concentrators, cylinders, liquid oxygen systems, and delivery interfaces such as masks, nasal cannulas, and ventilators. They are used across hospitals, clinics, and home care settings to support patients with chronic obstructive pulmonary disease (COPD), asthma, and other pulmonary conditions, helping maintain adequate oxygen saturation and improve overall respiratory function.

The growth of the oxygen therapy equipment market is being strongly driven by the rising incidence of respiratory conditions, the increasing use of these devices in critical care, and rapid technological innovations in product development. The growing prevalence of chronic respiratory diseases such as COPD, asthma, and sleep apnea, coupled with environmental factors like air pollution and smoking, has significantly increased the demand for oxygen therapy solutions across both hospital and home care settings. In critical care environments, oxygen therapy equipment plays a vital role in stabilizing patients suffering from respiratory distress, cardiac complications, and postoperative conditions, driving adoption in ICUs and emergency departments. Meanwhile, rapid advancements in device technology, including the development of compact, energy-efficient, and AI-integrated concentrators, are enhancing treatment accuracy, patient comfort, and mobility. Features such as real-time oxygen monitoring, automated flow adjustment, and wireless connectivity are making oxygen therapy more accessible and user-friendly, especially for long-term home use. Collectively, these factors are reinforcing the market's expansion by aligning technological progress with the growing clinical and home-based demand for reliable respiratory support solutions.

What are the latest Oxygen Therapy Equipment Market Dynamics and Trends?

The global oxygen therapy equipment market is witnessing strong and sustained growth, driven by a combination of clinical, demographic, environmental, and technological factors. The rising prevalence of chronic respiratory disorders such as asthma and chronic obstructive pulmonary disease (COPD) represents a major growth driver.

According to DelveInsight analysis (2025), over 250 million people globally are living with asthma, making it one of the most widespread chronic conditions across all age groups, while COPD cases are projected to reach 600 million by 2050. Environmental factors, including escalating air pollution, widespread tobacco use, climate change, occupational hazards, and rapid urbanization, have further contributed to the surge in respiratory ailments. In parallel, the expanding geriatric population, which is more vulnerable to chronic illnesses and repeated hospitalizations, is creating additional demand for oxygen therapy equipment across hospitals, critical care units, outpatient facilities, and home care settings.

The growing need for continuous oxygen support in critical care environments, where patients with severe respiratory distress, cardiac complications, or post-surgical conditions require reliable oxygen delivery, is further driving market adoption. At the same time, rapid technological advancements are transforming the sector. Innovations such as portable and stationary oxygen concentrators, AI-integrated monitoring systems, smart delivery devices, and user-friendly interfaces are enhancing treatment precision, improving patient comfort, and promoting adherence to therapy. The increasing focus on home-based care solutions, enabled by portable and connected devices, is also expanding access and convenience for patients managing long-term respiratory conditions.

Supportive regulatory frameworks, growing awareness about early diagnosis and timely intervention, and initiatives to improve patient education are further accelerating the adoption of oxygen therapy equipment. Collectively, these factors underscore the critical role of oxygen therapy solutions in modern healthcare, positioning the market for sustained growth. The convergence of rising disease prevalence, technological innovation, demographic shifts, and evolving care practices is driving a transformative shift toward advanced, patient-centric respiratory therapies that enhance clinical outcomes, improve quality of life, and meet the increasing demands of healthcare systems worldwide.

Despite strong growth potential, the oxygen therapy equipment market faces several key challenges that hinder its expansion. One major restraint is the presence of strict regulatory guidelines imposed by government authorities, which often result in lengthy and complex approval processes for new products. These regulations, while essential for ensuring patient safety and device efficacy, increase the time-to-market and impose additional financial burdens on manufacturers, particularly smaller or emerging companies.

In addition, the high cost of oxygen therapy, driven by advanced concentrators, maintenance requirements, and limited reimbursement support in certain regions, further restricts accessibility, especially in low- and middle-income countries. Together, these factors create significant barriers to market penetration, compelling manufacturers to focus on cost-effective innovations and compliance strategies to sustain growth in an increasingly regulated and cost-sensitive environment.

Oxygen Therapy Equipment Market Segment Analysis

Oxygen Therapy Equipment Market by Product Type (Systems [HFNO (High-Flow Nasal Cannula Oxygenation) Devices, Oxygen Concentrators, Ventilators, and Others] and Disposables and Accessories [Oxygen Masks, Nasal Cannulas, Resuscitator Bags, and Others]), Portability (Stationary and Portable), Application (COPD, Asthma, Respiratory Distress Syndrome, and Others), End-Users (Hospitals and Clinics, Ambulatory Surgical Centers, Home Care Settings, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)

Oxygen Therapy Equipment Market Regional Analysis

North America Oxygen Therapy Equipment Market Trends

North America, led by the United States, dominates the global oxygen therapy equipment market, accounting for approximately 42% of the total market share in 2024. The expansion of the North America oxygen therapy equipment market is being driven by several critical factors, foremost among them the rising prevalence of chronic respiratory diseases. According to the DelveInsight analysis (2024), more than 35.5 million people in the U.S. live with chronic lung conditions, including asthma and chronic obstructive pulmonary disease (COPD). Within this population, approximately 11.5 million adults, representing 4.6% of the U.S. adult population, have been diagnosed with COPD, encompassing chronic bronchitis and emphysema.

These progressive respiratory conditions impair pulmonary function and place a substantial burden on patients, caregivers, and the healthcare system. The rising incidence of COPD and asthma is directly accelerating demand for advanced oxygen therapy solutions. Patients with chronic respiratory conditions often require long-term supplemental oxygen, and the increasing need for reliable home-based oxygen therapy, portable concentrators, and smart oxygen delivery devices is reshaping market demand.

Technological innovations in oxygen therapy equipment, such as AI-integrated concentrators, real-time monitoring systems, and portable wearable devices, are enhancing patient safety, adherence, and treatment efficacy. These solutions enable continuous monitoring of blood oxygen levels, automated oxygen flow adjustments, and remote connectivity, ensuring patients receive consistent and effective therapy while reducing healthcare burdens.

In addition to disease prevalence, increased investment in respiratory research and patient support is shaping market dynamics. Organizations such as the American Lung Association continue to expand research funding and programs to improve awareness, early diagnosis, and management of lung diseases. These initiatives support the adoption of advanced oxygen therapy devices by educating patients, caregivers, and healthcare providers on proper usage, monitoring, and adherence.

Therefore, the combination of high disease prevalence, growing home healthcare adoption, technological innovation, increased research funding, and supportive patient programs is expected to drive sustained growth in the U.S. oxygen therapy equipment market over the forecast period from 2025 to 2032.

Europe Oxygen Therapy Equipment Market Trends

The growth of the European oxygen therapy equipment market is driven primarily by the rising prevalence of chronic diseases such as cancer and cardiovascular conditions, which necessitate repeated administration of medications and fluids through oxygen therapy devices. The increasing number of chemotherapy treatments, along with the growing utilization of these devices in pediatric patients, further contributes to market expansion.

Technological advancements in oxygen therapy equipment, including antimicrobial-coated catheters and sensor-enabled technologies, are improving patient safety and reducing complications such as infections and thrombosis. These innovations, combined with increased research activities and clinical trials across Europe, are accelerating the adoption of advanced devices. Currently, short peripheral intravenous catheters dominate the market in terms of revenue, while midline catheters represent the fastest-growing product segment due to their clinical advantages and improved patient outcomes.

Geographically, countries such as the United Kingdom, Germany, France, Spain, and Italy lead the market, with the UK expected to hold the largest share thanks to its advanced healthcare infrastructure and substantial investments in research and development. Regulatory compliance with the EU Medical Device Regulation (MDR) and the adoption of novel therapeutic approaches are also shaping market dynamics. Additionally, a noticeable shift toward home-infusion therapies and minimally invasive procedures is driving further demand for advanced vascular access and oxygen therapy solutions. Overall, the market reflects a balance of steady demand growth, continuous technological innovation, and evolving healthcare practices across Europe.

Asia-Pacific Oxygen Therapy Equipment Market Trends

The Asia-Pacific oxygen therapy equipment market is experiencing strong growth momentum, projected to register a 9.27% CAGR from 2025 to 2032. The market is expanding rapidly due to the rising prevalence of chronic respiratory diseases such as chronic obstructive pulmonary disease (COPD), asthma, and other pulmonary disorders, which increase the demand for oxygen therapy solutions. The region's large and aging population further contributes to market growth, as older adults are more likely to require long-term oxygen therapy. Countries such as India, China, and Japan are key markets, with India expected to register the highest growth rate.

Stationary and portable oxygen concentrators currently dominate the product segment, while portable and wearable devices are the fastest-growing due to their convenience and suitability for home-based care. Market expansion is also supported by ongoing healthcare infrastructure development, government initiatives to improve access to medical devices, and rising healthcare expenditure. Several regional and global players are actively investing in research and new product launches, driving technological advancements and improving device efficiency.

Additionally, increasing adoption of patient-friendly, minimally invasive oxygen delivery systems and the integration of smart monitoring and AI-powered features are shaping the market's upward trajectory. Thus, the Asia-Pacific region stands out as the fastest-growing market globally, driven by expanding patient populations, enhanced healthcare infrastructure, and continuous innovation in oxygen therapy equipment.

Who are the major players in the Oxygen Therapy Equipment Market?

The following are the leading companies in the oxygen therapy equipment market. These companies collectively hold the largest market share and dictate industry trends.

• Koninklijke Philips N.V.
• Invacare Corporation
• Inogen, Inc.
• Dragerwerk AG & Co. KgaA
• ICU Medical, Inc.
• CAIRE Inc.
• Fisher & Paykel Healthcare Limited
• Armstrong Medical
• Vyaire Medical, Inc.
• Hamilton Medical
• Shenzhen Comen Medical Instruments Co., Ltd.
• BMC Medical Co., Ltd.
• Allied Medical Limited
• Teleflex Incorporated
• HERSILL
• Chart Industries, Inc.
• DeVilbiss Healthcare LLC
• GCE Group
• Oxygen Solutions Inc.
• Besco Medical Limited

How is the competitive landscape shaping the Oxygen Therapy Equipment Market?

The competitive landscape of the oxygen therapy equipment market reflects a balance between established global corporations and emerging innovators. The market is highly consolidated, with major players such as Philips Respironics, Inogen, CAIRE Inc., Linde Healthcare, and ResMed holding significant market share, particularly in high-tech stationary and portable oxygen concentrators, liquid oxygen systems, and advanced delivery interfaces. These leaders maintain their dominance through continuous research and development, strong brand recognition, and diversified product portfolios that cater to a wide range of respiratory care needs across hospitals, home care, and long-term care settings.

At the same time, smaller, agile companies and startups are reshaping the market by introducing innovative solutions and smart oxygen therapy technologies. Many of these new entrants are driving growth in emerging segments, including AI-powered monitoring systems, portable and wearable concentrators, and devices with enhanced connectivity and patient-friendly designs. By enabling real-time monitoring, automated oxygen delivery adjustments, and remote management, they are supporting a shift from hospital-centric care to more flexible, home-based, and outpatient respiratory care.

This interplay between established incumbents and innovative disruptors is fostering a competitive environment characterized by rapid technological advancement and strategic collaborations. Larger corporations are increasingly engaging in partnerships, acquisitions, and technology integrations to enhance device efficiency, expand product portfolios, and maintain market leadership. As a result, competition is driving not only innovation and improved patient outcomes but also accelerating the adoption of more convenient, efficient, and patient-centric oxygen therapy solutions worldwide.

Recent Developmental Activities in the Oxygen Therapy Equipment Market

• In June 2025, Inogen, Inc., a prominent medical technology company focused on advanced respiratory solutions for home care, unveiled the Voxi(TM) 5, a new stationary oxygen concentrator (SOC) aimed at improving access to high-quality oxygen therapy for long-term care patients in the United States. This latest addition to Inogen's product lineup complements its range of portable oxygen concentrators, broadening market opportunities and capitalizing on the company's established distribution and sales channels.
• In June 2025, VARON, a global respiratory care company, officially introduced a new platform specifically designed for the Mexican market, responding to the growing healthcare priority of providing reliable home oxygen therapy amid rising chronic respiratory conditions in the country.
• In January 2025, Caire announced the launch of its new IntenOxy 5 stationary oxygen concentrator. According to the company, the device is now available for purchase in the United States and Puerto Rico, with plans to expand availability to Canada in the near future.

Oxygen Therapy Equipment Market Segmentation

• Oxygen Therapy Equipment Product Type Exposure
• Systems
• HFNO (High-Flow Nasal Cannula Oxygenation) Devices
• Oxygen Concentrators
• Ventilators
• Others
• Disposables and Accessories
• Oxygen Masks
• Nasal Cannulas
• Resuscitator Bags
• Others
• Oxygen Therapy Equipment Portability Exposure
• Stationary
• Portable
• Oxygen Therapy Equipment Application Exposure
• COPD
• Asthma
• Respiratory Distress Syndrome
• Others
• Oxygen Therapy Equipment End-Users Exposure
• Hospitals and Clinics
• Ambulatory Surgical Centers
• Home Care Settings
• Others
• Oxygen Therapy Equipment Geography Exposure
• North America Oxygen Therapy Equipments Market
• United States Oxygen Therapy Equipments Market
• Canada Oxygen Therapy Equipments Market
• Mexico Oxygen Therapy Equipments Market
• Europe Oxygen Therapy Equipments Market
• United Kingdom Oxygen Therapy Equipments Market
• Germany Oxygen Therapy Equipments Market
• France Oxygen Therapy Equipments Market
• Italy Oxygen Therapy Equipments Market
• Spain Oxygen Therapy Equipments Market
• Rest of Europe Oxygen Therapy Equipments Market
• Asia-Pacific Oxygen Therapy Equipments Market
• China Oxygen Therapy Equipments Market
• Japan Oxygen Therapy Equipments Market
• India Oxygen Therapy Equipments Market
• Australia Oxygen Therapy Equipments Market
• South Korea Oxygen Therapy Equipments Market
• Rest of Asia-Pacific Oxygen Therapy Equipments Market
• Rest of the World Oxygen Therapy Equipments Market
• South America Oxygen Therapy Equipments Market
• Middle East Oxygen Therapy Equipments Market
• Africa Oxygen Therapy Equipments Market

Impact Analysis

AI-Powered Innovations and Applications:

Artificial intelligence is rapidly transforming the oxygen therapy equipment market by enabling smarter, more personalized, and efficient respiratory care solutions. AI-powered oxygen concentrators and delivery systems can monitor a patient's oxygen saturation in real time, analyze trends, and automatically adjust flow rates to maintain optimal blood oxygen levels. These intelligent systems improve therapeutic outcomes and reduce the risk of over- or under-oxygenation, which is particularly critical for patients with chronic respiratory conditions.

Beyond automated flow regulation, AI integration facilitates remote monitoring and predictive maintenance, allowing healthcare providers to track patient compliance, detect anomalies, and anticipate device malfunctions before they occur. Machine learning algorithms can also analyze large datasets from multiple patients to identify patterns, optimize treatment protocols, and support clinical decision-making. Additionally, AI-driven solutions are enhancing the usability of portable oxygen devices, providing voice-assisted controls, mobile app connectivity, and real-time alerts for low battery or depleted oxygen supply. Thus, AI innovations are improving patient safety, treatment effectiveness, and the accessibility of oxygen therapy in both home and clinical settings.

U.S. Tariff Impact Analysis on the Oxygen Therapy Equipment Market:

The imposition of U.S. tariffs on imported medical devices and raw materials has had a mixed impact on the oxygen therapy equipment market. While the broader intent of tariffs is to encourage domestic manufacturing and reduce reliance on foreign supply chains, they have also led to cost pressures across the value chain. Many oxygen concentrators, cylinders, and parts such as valves, compressors, and sensors are sourced or assembled from international suppliers, particularly in China, Germany, and Japan. Tariffs on these imported components have increased production costs for U.S.-based manufacturers, resulting in higher end-user prices and potentially limiting affordability for healthcare providers and home care patients.

During the COVID-19 pandemic, the United States temporarily eased certain medical device tariffs to ensure an uninterrupted oxygen supply, but as trade tensions continue, the long-term tariff structure remains uncertain. Manufacturers have responded by diversifying supply chains, localizing production, and investing in automation to offset higher import duties. However, smaller and mid-sized companies face tighter profit margins due to limited capacity to absorb these added costs.

On the positive side, tariffs have encouraged domestic innovation and the reshoring of key oxygen therapy device manufacturing, particularly in critical components like filters and sensors. Therefore, while tariffs create short-term challenges through increased manufacturing and logistics costs, they may support long-term resilience and technological self-reliance within the U.S. oxygen therapy equipment market.

How This Analysis Helps Clients

• Cost Management: By understanding the tariff landscape, clients can anticipate cost increases and adjust pricing strategies accordingly, ensuring profitability.
• Supply Chain Optimization: Clients can identify alternative sourcing options and diversify their supply chains to reduce dependency on high-tariff regions, enhancing resilience.
• Regulatory Navigation: Expert guidance on navigating the evolving regulatory environment helps clients maintain compliance and avoid potential legal challenges.
• Strategic Planning: Insights into tariff impacts enable clients to make informed decisions about manufacturing locations, partnerships, and market entry strategies.

Key takeaways from the Oxygen Therapy Equipment market report study

• Market size analysis for the current oxygen therapy equipment market size (2024), and market forecast for 8 years (2025 to 2032)
• Top key product/technology developments, mergers, acquisitions, partnerships, and joint ventures happened over the last 3 years.
• Key companies dominating the oxygen therapy equipment market.
• Various opportunities available for the other competitors in the oxygen therapy equipment market.
• What are the top-performing segments in 2024? How these segments will perform in 2032?
• Which are the top-performing regions and countries in the current oxygen therapy equipment market scenario?
• Which are the regions and countries where companies should have concentrated on opportunities for the oxygen therapy equipment market growth in the future?

Frequently Asked Questions for the Oxygen Therapy Equipment Market

1. What is the growth rate of the oxygen therapy equipment market?

• The oxygen therapy equipment market is estimated to grow at a CAGR of 7.52% during the forecast period from 2025 to 2032.

2. What is the market for oxygen therapy equipment?

• The oxygen therapy equipment market was valued at USD 3,295.77 million in 2024 and is expected to reach USD 5,866.74 million by 2032.

3. Which region has the highest share in the oxygen therapy equipment market?

• North America holds the highest share in the global oxygen therapy equipment market, driven by a well-established healthcare infrastructure, a high prevalence of chronic respiratory and other chronic diseases, and a growing aging population. The region's advanced adoption of medical technologies, including portable and stationary oxygen concentrators, AI-integrated monitoring systems, and smart oxygen delivery devices, further reinforces its market dominance. Rising demand for home-based oxygen therapy, coupled with continuous technological innovation and supportive patient programs, is accelerating adoption and ensuring sustained growth. These factors collectively position North America as a leading and highly influential market in the global oxygen therapy equipment landscape.

4. What are the drivers for the oxygen therapy equipment market?

• The global oxygen therapy equipment market is witnessing robust growth driven by the rising prevalence of respiratory diseases, expanding use in critical care, and rapid technological advancements. Increasing cases of COPD, asthma, and other chronic lung conditions have heightened the demand for continuous oxygen support in both hospitals and home care settings. In critical care units, oxygen devices are indispensable for managing patients with severe respiratory or cardiac complications. Simultaneously, innovations such as AI-integrated concentrators, real-time monitoring, and portable designs are improving treatment precision and patient convenience. Together, these factors are fueling widespread adoption and strengthening the market's growth trajectory.

5. Who are the key players operating in the oxygen therapy equipment market?

• Some of the key market players operating in the oxygen therapy equipment market include Koninklijke Philips N.V., Invacare Corporation, Inogen, Inc., Dragerwerk AG & Co. KgaA, ICU Medical, Inc., CAIRE Inc., Fisher & Paykel Healthcare Limited, Armstrong Medical, Vyaire Medical, Inc., Hamilton Medical, Shenzhen Comen Medical Instruments Co., Ltd., BMC Medical Co., Ltd., Allied Medical Limited, Teleflex Incorporated, HERSILL, Chart Industries, Inc., DeVilbiss Healthcare LLC, GCE Group, Oxygen Solutions Inc., Besco Medical Limited, and Others.

Table of Contents

1. Oxygen Therapy Equipment Market Report Introduction

• 1.1 Scope of the Study
• 1.2 Market Segmentation
• 1.3 Market Assumption

2. Oxygen Therapy Equipment Market Executive Summary

• 2.1 Market at Glance

3. Oxygen Therapy Equipment Market Key Factors Analysis

• 3.1 Oxygen Therapy Equipment Market Drivers
  • 3.1.1 Increase in the cases of respiratory disorders
  • 3.1.2 Significant usage of these devices in critical care
  • 3.1.3 Rapid technical innovation in product development
• 3.2 Oxygen Therapy Equipment Market Restraints and Challenges
  • 3.2.1 Strict regulatory guidelines by the government are causing delays in product approvals
  • 3.2.2 The high cost of therapy
• 3.3 Oxygen Therapy Equipment Market Opportunity
  • 3.3.1 Untapped potential of emerging markets
  • 3.3.2 Increasing awareness regarding oxygen therapy

4. Impact Analysis

• 4.1 AI-Powered Innovations and Applications
• 4.2 U.S. Tariff Impact Analysis

5. Regulatory Analysis

• 5.1 The United States
• 5.2 Europe
• 5.3 Japan
• 5.4 China

6. Oxygen Therapy Equipment Market Porter's Five Forces Analysis

• 6.1 Bargaining Power of Suppliers
• 6.2 Bargaining Power of Consumers
• 6.3 Threat of New Entrants
• 6.4 Threat of Substitutes
• 6.5 Competitive Rivalry

7. Oxygen Therapy Equipment Market Assessment

• 7.1 By Product Type
  • 7.1.1 Systems
    • 7.1.1.1 HFNO (High-Flow Nasal Cannula Oxygenation) Devices
    • 7.1.1.2 Oxygen Concentrators
    • 7.1.1.3 Ventilators
    • 7.1.1.4 Others
  • 7.1.2 Disposables and Accessories
    • 7.1.2.1 Oxygen Masks
    • 7.1.2.2 Nasal Cannulas
    • 7.1.2.3 Resuscitator Bags
    • 7.1.2.4 Others
• 7.2 By Portability
  • 7.2.1 Stationary
  • 7.2.2 Portable
• 7.3 By Applications
  • 7.3.1 COPD
  • 7.3.2 Asthma
  • 7.3.3 Respiratory Distress Syndrome
  • 7.3.4 Others
• 7.4 By End-Users
  • 7.4.1 Hospitals and Clinics
  • 7.4.2 Ambulatory Surgical Centers
  • 7.4.3 Home Care Settings
  • 7.4.4 Others
• 7.5 By Geography
  • 7.5.1 North America
    • 7.5.1.1 United States Oxygen Therapy Equipment Market Size in USD million (2022-2032)
    • 7.5.1.2 Canada Oxygen Therapy Equipment Market Size in USD million (2022-2032)
    • 7.5.1.3 Mexico Oxygen Therapy Equipment Market Size in USD million (2022-2032)
  • 7.5.2 Europe
    • 7.5.2.1 France Oxygen Therapy Equipment Market Size in USD million (2022-2032)
    • 7.5.2.2 Germany Oxygen Therapy Equipment Market Size in USD million (2022-2032)
    • 7.5.2.3 United Kingdom Oxygen Therapy Equipment Market Size in USD million (2022-2032)
    • 7.5.2.4 Italy Oxygen Therapy Equipment Market Size in USD million (2022-2032)
    • 7.5.2.5 Spain Oxygen Therapy Equipment Market Size in USD million (2022-2032)
    • 7.5.2.6 Rest of Europe Oxygen Therapy Equipment Market Size in USD million (2022-2032)
  • 7.5.3 Asia-Pacific
    • 7.5.3.1 China Oxygen Therapy Equipment Market Size in USD million (2022-2032)
    • 7.5.3.2 Japan Oxygen Therapy Equipment Market Size in USD million (2022-2032)
    • 7.5.3.3 India Oxygen Therapy Equipment Market Size in USD million (2022-2032)
    • 7.5.3.4 Australia Oxygen Therapy Equipment Market Size in USD million (2022-2032)
    • 7.5.3.5 South Korea Oxygen Therapy Equipment Market Size in USD million (2022-2032)
    • 7.5.3.6 Rest of Asia-Pacific Oxygen Therapy Equipment Market Size in USD million (2022-2032)
  • 7.5.4 Rest of the World (RoW)
    • 7.5.4.1 Middle East Oxygen Therapy Equipment Market Size in USD million (2022-2032)
    • 7.5.4.2 Africa Oxygen Therapy Equipment Market Size in USD million (2022-2032)
    • 7.5.4.3 South America Oxygen Therapy Equipment Market Size In USD Million (2022-2032)

8. Competitive Landscape

9. Startup Funding & Investment Trends

10. Oxygen Therapy Equipment Market Company and Product Profiles

• 10.1 Koninklijke Philips N.V.
  • 10.1.1 Company Overview
  • 10.1.2 Company Snapshot
  • 10.1.3 Financial Overview
  • 10.1.4 Product Listing
  • 10.1.5 Entropy
• 10.2 Invacare Corporation
  • 10.2.1 Company Overview
  • 10.2.2 Company Snapshot
  • 10.2.3 Financial Overview
  • 10.2.4 Product Listing
  • 10.2.5 Entropy
• 10.3 Inogen, Inc.
  • 10.3.1 Company Overview
  • 10.3.2 Company Snapshot
  • 10.3.3 Financial Overview
  • 10.3.4 Product Listing
  • 10.3.5 Entropy
• 10.4 Dragerwerk AG & Co. KgaA
  • 10.4.1 Company Overview
  • 10.4.2 Company Snapshot
  • 10.4.3 Financial Overview
  • 10.4.4 Product Listing
  • 10.4.5 Entropy
• 10.5 ICU Medical, Inc.
  • 10.5.1 Company Overview
  • 10.5.2 Company Snapshot
  • 10.5.3 Financial Overview
  • 10.5.4 Product Listing
  • 10.5.5 Entropy
• 10.6 CAIRE Inc.
  • 10.6.1 Company Overview
  • 10.6.2 Company Snapshot
  • 10.6.3 Financial Overview
  • 10.6.4 Product Listing
  • 10.6.5 Entropy
• 10.7 Fisher & Paykel Healthcare Limited
  • 10.7.1 Company Overview
  • 10.7.2 Company Snapshot
  • 10.7.3 Financial Overview
  • 10.7.4 Product Listing
  • 10.7.5 Entropy
• 10.8 Armstrong Medical
  • 10.8.1 Company Overview
  • 10.8.2 Company Snapshot
  • 10.8.3 Financial Overview
  • 10.8.4 Product Listing
  • 10.8.5 Entropy
• 10.9 Vyaire Medical, Inc.
  • 10.9.1 Company Overview
  • 10.9.2 Company Snapshot
  • 10.9.3 Financial Overview
  • 10.9.4 Product Listing
  • 10.9.5 Entropy
• 10.10 Hamilton Medical
  • 10.10.1 Company Overview
  • 10.10.2 Company Snapshot
  • 10.10.3 Financial Overview
  • 10.10.4 Product Listing
  • 10.10.5 Entropy
• 10.11 Shenzhen Comen Medical Instruments Co., Ltd.
  • 10.11.1 Company Overview
  • 10.11.2 Company Snapshot
  • 10.11.3 Financial Overview
  • 10.11.4 Product Listing
  • 10.11.5 Entropy
• 10.12 BMC Medical Co., Ltd.
  • 10.12.1 Company Overview
  • 10.12.2 Company Snapshot
  • 10.12.3 Financial Overview
  • 10.12.4 Product Listing
  • 10.12.5 Entropy
• 10.13 Allied Medical Limited
  • 10.13.1 Company Overview
  • 10.13.2 Company Snapshot
  • 10.13.3 Financial Overview
  • 10.13.4 Product Listing
  • 10.13.5 Entropy
• 10.14 Teleflex Incorporated
  • 10.14.1 Company Overview
  • 10.14.2 Company Snapshot
  • 10.14.3 Financial Overview
  • 10.14.4 Product Listing
  • 10.14.5 Entropy
• 10.15 HERSILL
  • 10.15.1 Company Overview
  • 10.15.2 Company Snapshot
  • 10.15.3 Financial Overview
  • 10.15.4 Product Listing
  • 10.15.5 Entropy
• 10.16 Chart Industries, Inc.
  • 10.16.1 Company Overview
  • 10.16.2 Company Snapshot
  • 10.16.3 Financial Overview
  • 10.16.4 Product Listing
  • 10.16.5 Entropy
• 10.17 DeVilbiss Healthcare LLC
  • 10.17.1 Company Overview
  • 10.17.2 Company Snapshot
  • 10.17.3 Financial Overview
  • 10.17.4 Product Listing
  • 10.17.5 Entropy
• 10.18 GCE Group
  • 10.18.1 Company Overview
  • 10.18.2 Company Snapshot
  • 10.18.3 Financial Overview
  • 10.18.4 Product Listing
  • 10.18.5 Entropy
• 10.19 Oxygen Solutions Inc.
  • 10.19.1 Company Overview
  • 10.19.2 Company Snapshot
  • 10.19.3 Financial Overview
  • 10.19.4 Product Listing
  • 10.19.5 Entropy
• 10.20 Besco Medical Limited
  • 10.20.1 Company Overview
  • 10.20.2 Company Snapshot
  • 10.20.3 Financial Overview
  • 10.20.4 Product Listing
  • 10.20.5 Entropy

11. KOL Views

12. Project Approach

13. About DelveInsight

14. Disclaimer & Contact Us